C. Fountzilas and V. G. Kaklamani, Multi-Gene panel testing in breast cancer management, Cancer Treat Res, vol.173, pp.121-161, 2018.

S. M. Domchek, A. Bradbury, and J. E. Garber, Multiplex genetic testing for cancer susceptibility: out on the high wire without a net?, JCO, vol.31, pp.1267-70, 2013.

F. J. Couch, K. L. Nathanson, and K. Offit, Two decades after BRCA: setting paradigms in personalized cancer care and prevention, Science, vol.343, pp.1466-70, 2014.

, , 2019.

A. Taylor, A. F. Brady, and I. M. Frayling, Consensus for genes to be included on cancer panel tests offered by UK genetics services: guidelines of the UK cancer genetics group, J Med Genet, vol.55, pp.372-379, 2018.

B. Meiser, Psychological impact of genetic testing for cancer susceptibility: an update of the literature, Psychooncology, vol.14, pp.1060-74, 2005.

A. M. Hirschberg, G. Chan-smutko, and W. F. Pirl, Psychiatric implications of cancer genetic testing, Cancer, vol.121, pp.341-60, 2015.

W. Eijzenga, D. Hahn, and N. K. Aaronson, Specific psychosocial issues of individuals undergoing genetic counseling for cancer -a literature review, J Genet Couns, vol.23, pp.133-179, 2014.

J. Vos, C. J. Van-asperen, and J. C. Oosterwijk, The counselees' selfreported Request for psychological help in genetic counseling for hereditary breast/ovarian cancer: not only psychopathology matters, Psychooncology, vol.22, pp.902-912, 2013.

D. Gadzicki, D. G. Evans, and H. Harris, Genetic testing for familial/hereditary breast cancer-comparison of guidelines and recommendations from the UK, France, the Netherlands and Germany, J Community Genet, vol.2, pp.53-69, 2011.

R. Kreienberg, U. Albert, and M. Follmann, Interdisciplinary GoR level III guidelines for the diagnosis, therapy and follow-up care of breast cancer, Geburtshilfe Frauenheilkd, vol.73, pp.556-83, 2013.

G. Llort, I. Chirivella, and R. Morales, SEOM clinical guidelines in hereditary breast and ovarian cancer, Clin Transl Oncol, vol.17, pp.956-61, 2015.

J. Moretta, P. Berthet, and V. Bonadona, The French Genetic and Cancer Consortium guidelines for multigene panel analysis in hereditary breast and ovarian cancer predisposition, Bull Cancer, vol.105, pp.907-924, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02146849

R. G. Resta, What have we been trying to do and have we been any good at it? a history of measuring the success of genetic counseling, Eur J Med Genet, 2018.

D. Cragun and H. Zierhut, Development of FOCUS-GC: framework for outcomes of clinical communication services in genetic counseling, J Genet Couns, vol.27, pp.33-58, 2018.

T. P. Slavin, M. Niell-swiller, and I. Solomon, Clinical application of multigene panels: challenges of next-generation counseling and cancer risk management, Front Oncol, vol.5, 2015.

D. F. Easton, P. Pharoah, and A. C. Antoniou, Gene-panel sequencing and the prediction of breast-cancer risk, N Engl J Med, vol.372, pp.2243-57, 2015.

S. Hiraki, E. S. Rinella, and F. Schnabel, Cancer risk assessment using genetic panel testing: considerations for clinical application, J Genet Couns, vol.23, pp.604-621, 2014.

D. M. Eccles, G. Mitchell, and A. Monteiro, BRCA1 and BRCA2 genetic testing-pitfalls and recommendations for managing variants of uncertain clinical significance, Ann Oncol, vol.26, pp.2057-65, 2015.

J. G. Hamilton, M. Lobel, and A. Moyer, Emotional distress following genetic testing for hereditary breast and ovarian cancer: a meta-analytic review, Health Psychol, vol.28, pp.510-518, 2009.

L. Stafford, A. Flehr, and F. Judd, Experiences and interpretations of BRCA1/2 testing among women affected by breast or ovarian cancer who received a negative result, J Community Genet, vol.72, 2019.

J. Vos, E. Gómez-garcía, and J. C. Oosterwijk, Opening the psychological black box in genetic counseling. The psychological impact of DNA testing is predicted by the counselees' perception, the medical impact by the pathogenic or uninformative BRCA1/2-result, Psychooncology, vol.21, pp.29-42, 2012.

S. Makhnoon, L. T. Garrett, and W. Burke, Experiences of patients seeking to participate in variant of uncertain significance reclassification research, J Community Genet, vol.10, pp.189-96, 2019.

C. Rini, S. C. O'neill, and H. Valdimarsdottir, Cognitive and emotional factors predicting decisional conflict among high-risk breast cancer survivors who receive uninformative BRCA1/2 results, Health Psychology, vol.28, pp.569-78, 2009.

S. C. O'neill, C. Rini, and R. E. Goldsmith, Distress among women receiving uninformative BRCA1/2 results: 12-month outcomes, Psychooncology, vol.18, pp.1088-96, 2009.

D. O. Himes, D. K. Gibbons, and W. C. Birmingham, Female family members lack understanding of indeterminate negative BRCA1/2 test results shared by probands, J Genet Couns, vol.25, 2019.

M. L. Murray, F. Cerrato, and R. L. Bennett, Follow-Up of carriers of BRCA1 and BRCA2 variants of unknown significance: variant reclassification and surgical decisions, Genetics in Medicine, vol.13, pp.998-1005, 2011.

C. Maheu, T. Apostolidis, and A. Petri-cal, French women's breast self-examination practices with time after undergoing BRCA1/2 genetic testing, Fam Cancer, vol.11, pp.269-78, 2012.

I. Esteban, M. Vilaró, and E. Adrover, Psychological impact of multigene cancer panel testing in patients with a clinical suspicion of hereditary cancer across Spain, Psychooncology, vol.27, pp.1530-1537, 2018.

A. R. Bradbury, L. J. Patrick-miller, and B. L. Egleston, Patient feedback and early outcome data with a novel tiered-binned model for multiplex breast cancer susceptibility testing, Genet Med, vol.18, pp.25-33, 2016.

H. S. Lumish, H. Steinfeld, and C. Koval, Impact of panel gene testing for hereditary breast and ovarian cancer on patients, J Genet Couns, vol.26, pp.1116-1145, 2017.

W. Eijzenga, E. Bleiker, and D. Hahn, Psychosocial aspects of hereditary cancer (PAHC) questionnaire: development and testing of a screening questionnaire for use in clinical cancer genetics, Psychooncology, vol.23, pp.862-871, 2014.

A. Farrelly, V. White, and B. Meiser, Unmet support needs and distress among women with a BRCA1/2 mutation, Fam Cancer, vol.12, pp.509-527, 2013.

S. C. O'neill, C. Evans, and R. J. Hamilton, Information and support needs of young women regarding breast cancer risk and genetic testing: adapting effective interventions for a novel population, Fam Cancer, vol.17, pp.351-60, 2018.

T. M. Beran, A. L. Stanton, and L. Kwan, The trajectory of psychological impact in BRCA1/2 genetic testing: does time heal?, ann. behav. med, vol.36, pp.107-123, 2008.

C. H. Halbert, J. E. Stopfer, and J. Mcdonald, Long-Term Reactions to Genetic Testing for BRCA1 and BRCA2 Mutations: Does Time Heal Women's Concerns?, JCO, vol.29, pp.4302-4308, 2011.

A. Brédart, J. L. Kop, and A. Depauw, Short-Term psychological impact of the BRCA1/2 test result in women with breast cancer according to their perceived probability of genetic predisposition to cancer, Br J Cancer, vol.108, pp.1012-1032, 2013.

J. P. Vandenbroucke, E. Von-elm, and D. G. Altman, Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration, PLoS Med, vol.4, p.297, 2007.

, Biomedicine Agency FHHA. Règles de bonnes pratiques en génétique constitutionnelle des fins médicales (hors diagnostic prénatal), 2013.

A. J. Lee, A. P. Cunningham, and K. B. Kuchenbaecker, Boadicea breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface, Br J Cancer, vol.110, pp.535-580, 2014.

G. W. Hooker, K. R. Clemens, and J. Quillin, Cancer genetic counseling and testing in an era of rapid change, J Genet Couns, vol.26, pp.1244-53, 2017.

D. Kuli?, A. Bottomley, and G. Velikova, EORTC quality of life group translation procedure, 2017.

D. Razavi, N. Delvaux, and C. Farvacques, Screening for adjustment disorders and major depressive disorders in cancer in-patients, Br J Psychiatry, vol.156, pp.79-83, 1990.

C. Herrmann-lingen and R. P. Snaith, HADS-D: Hospital Anxiety and Depression Scale -German; Manual, 2011.

M. J. Herrero, J. Blanch, and J. M. Peri, A validation study of the hospital anxiety and depression scale (HADS) in a Spanish population, Gen Hosp Psychiatry, vol.25, pp.277-83, 2003.

W. Söllner, A. Devries, and E. Steixner, How successful are oncologists in identifying patient distress, perceived social support, and need for psychosocial counselling?, Br J Cancer, vol.84, pp.179-85, 2001.

. Team and . Rc, R: A language and environment for statistical computing, 2017.

A. Brédart, A. Anota, and J. Dick, Patient-Centered care in breast cancer genetic clinics, Int J Environ Res Public Health, vol.15, p.319, 2018.

W. Eijzenga, E. Bleiker, and D. Hahn, Prevalence and detection of psychosocial problems in cancer genetic counseling, Fam Cancer, vol.14, pp.629-665, 2015.

B. G. Tabachnick and L. S. Fidell, Using multivariate statistics, fifth edition, 2007.

. O'brien-rm, A caution regarding rules of thumb for variance inflation factors, Qual Quant, vol.41, pp.673-90, 2007.

M. Bjørnslett, A. A. Dahl, and S. Øystein, Psychological distress related to BRCA testing in ovarian cancer patients, Fam Cancer, vol.14, pp.495-504, 2015.

J. Vos, J. C. Oosterwijk, and E. Gomez-garcia, Exploring the short-term impact of DNA-testing in breast cancer patients: The counselees' perception matters, but the actual BRCA1/2 result does not, Patient Educ Couns, vol.86, pp.239-51, 2012.

K. Douma, E. Smets, and D. C. Allain, Non-genetic health professionals' attitude towards, knowledge of and skills in discussing and ordering genetic testing for hereditary cancer, Fam Cancer, vol.15, pp.341-50, 2016.

S. Makhnoon, B. H. Shirts, and D. J. Bowen, Patients' perspectives of variants of uncertain significance and strategies for uncertainty management, J Genet Couns, vol.28, pp.313-338, 2019.

W. Eijzenga, E. Bleiker, and M. Ausems, Routine assessment of psychosocial problems after cancer genetic counseling: results from a randomized controlled trial, Clin Genet, vol.87, pp.419-446, 2015.

I. Eisler, M. Ellison, and F. Flinter, Developing an intervention to facilitate family communication about inherited genetic conditions, and training genetic counsellors in its delivery, Eur J Hum Genet, vol.24, pp.794-802, 2016.

D. J. Bowen, T. Hyams, and M. Laurino, Development of FamilyTalk: an intervention to support communication and educate families about colorectal cancer risk, J Canc Educ, vol.67, 2019.

M. Cunningham, M. Morreale, and A. Trepanier, Referrals to mental health services: exploring the referral process in genetic counseling, J Genet Couns, vol.27, pp.289-300, 2018.

C. Maheu, A. Bouhnik, and C. Nogues, Which factors predict proposal and uptake of psychological counselling after BRCA1/2 test result disclosure?, Psychooncology, vol.23, pp.420-427, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-01997016

R. Fielding, W. Lam, and S. C. Shun, Attributing variance in supportive care needs during cancer: culture-service, and individual differences, before clinical factors, PLoS One, vol.8, p.65099, 2013.

C. Bonaïti-pellié, N. Andrieu, and P. Arveux,

, Bull Cancer, vol.96, pp.875-900, 2009.

G. W. Hooker, D. Babu, and M. F. Myers, Standards for the reporting of genetic counseling interventions in research and other studies (GCIRS): an NSGC Task force report, J Genet Couns, vol.26, pp.355-60, 2017.